Medtronic stock slides 1.20% and underperforms competitors

10 articles · Updated · MarketWatch · May 1

The shares closed at $80.00 as the S&P 500 rose 0.29% to 7,230.12 and the Dow fell 0.31% to 49,499.27.
Medtronic ended 24.76% below its 52-week high of $106.33 reached on 26 November, despite rivals Johnson & Johnson, Danaher and Abbott also declining.
Trading volume was 8.3 million shares, about 139,660 below its 50-day average of 8.4 million, indicating slightly lighter-than-usual activity.

With record growth and new FDA approvals, why does Medtronic's stock continue to underperform?

Can Medtronic's new Hugo robot successfully challenge Intuitive Surgical's dominance in robotic surgery?